Amgen Inc. buy BMO Capital Markets
Start price
19.12.23
/
50%
€253.60
Target price
19.12.24
€297.31
Performance (%)
14.76%
Price
13:27
€288.95
Summary
This prediction is currently active. The prediction currently has a performance of 14.76%. A total of €2.09 was paid as dividends for this prediction. This prediction currently runs until 19.12.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 14.603% | 14.603% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $326.00 price target on the stock, up previously from $286.00.
Ratings data for AMGN provided by MarketBeat